[1] Tian XT, Xu YJ, Yang YQ. Gender differences in arrhythmias: focused on atrial fibrillation[J]. J Cardiovasc Transl Res, 2020, 13(1):85-96.
[2] Qin D, Mansour MC, Ruskin JN, et al. Atrial fibrillation-mediated cardiomyopathy[J]. Circ Arrhythm Electrophysiol, 2019, 12(12):e007809.
[3] Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation[J]. Heart, 2019, 105(24):1860-1867.
[4] Lau DH, Nattel S, Kalman JM, et al. Modifiable risk factors and atrial fibrillation[J]. Circulation, 2017, 136(6):583-596.
[5] Roselli C, Rienstra M, Ellinor PT. Genetics of atrial fibrillation in 2020: GWAS, genome sequencing, polygenic risk, and beyond[J]. Circ Res, 2020, 127(1):21-33.
[6] Li N, Wang ZS, Wang XH, et al. A SHOX2 loss-of-function mutation underlying familial atrial fibrillation[J]. Int J Med Sci, 2018, 15(13):1564-1572.
[7] Jeyaraj D, Haldar SM, Wan X, et al. Circadian rhythms govern cardiac repolarization and arrhythmogenesis[J]. Nature, 2012, 483(7387):96-99.
[8] Olesen MS, Refsgaard L, Holst AG, et al. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation[J]. Cardiovasc Res, 2013, 98(3):488-495.
[9] 董斌斌, 刘兴元, 杨奕清. 先天性心脏缺损相关 NR2F2 基因新突变研究[J]. 国际心血管病杂志, 2019, 46(4):240-243.
[10] 乔祺, 杨晨曦, 顾佳宁, 等. 散发性扩张型心肌病相关ISL1基因突变分析[J]. 国际心血管病杂志, 2020, 47(3):162-167.
[11] Xu YJ, Wang ZS, Yang CX, et al. Identification and functional characterization of an ISL1 mutation predisposing to dilated cardiomyopathy[J]. J Cardiovasc Transl Res, 2019, 12(3):257-267.
[12] Yamamoto J, Ikeda Y, Iguchi H, et al. A Kruppel-like factor KLF15 contributes fasting-induced transcriptional activation of mitochondrial acetyl-CoA synthetase gene AceCS2[J]. J Biol Chem, 2004, 279(17):16954-16962.
[13] Prosdocimo DA, Anand P, Liao X, et al. Kruppel-like factor 15 is a critical regulator of cardiac lipid metabolism[J]. J Biol Chem, 2014, 289(9):5914-5924.
[14] Gray S, Feinberg MW, Hull S, et al. The Krüppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4[J]. J Biol Chem, 2002, 277(37):34322-34328.
[15] Niwa N, Nerbonne JM. Molecular determinants of cardiac transient outward potassium current(I(to))expression and regulation[J]. J Mol Cell Cardiol, 2010, 48(1):12-25.
[16] Kuo HC, Cheng CF, Clark RB, et al. A defect in the Kv channel-interacting protein 2(KChIP2)gene leads to a complete loss of I(to)and confers susceptibility to ventricular tachycardia[J]. Cell, 2001, 107(6):801-813.
[17] Qiu J, Zhou S, Liu Q. Energy metabolic alterations in the progression of atrial fibrillation:Potential role of AMP-activated protein kinase as a critical regulator[J]. Int J Cardiol, 2016, 212:14-15.
[18] Nattel S. Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation[J]. JACC Clin Electrophysiol, 2017, 3(5):425-435.
[19] Wang B, Haldar SM, Lu Y, et al. The Kruppel-like factor KLF15 inhibits connective tissue growth factor(CTGF)expression in cardiac fibroblasts[J]. J Mol Cell Cardiol, 2008, 45(2):193-197.